Tag: Pyelonephritis

Acute pyelonephritis affects up to 25.9 million people annually worldwide. When treating this serious kidney infection, selecting the right medication is critical for effective treatment and to prevent complications. This article explores which of the following medications is not recommended in the treatment of acute pyelonephritis and explains the pharmacological rationale behind these guidelines.

Annually, kidney infections (pyelonephritis) account for about 250,000 office visits and 200,000 hospital admissions in the United States. This article examines the question: Does cephalexin treat kidney infections, and what is its place in current therapeutic guidelines?